MIG Capital Closes $2 Million Series A Financing of Butterfly Medical

MIG Capital, a Newport Beach-based alternative investment firm, closed its investment in the $1.2 million Series A-1 preferred stock financing of Butterfly Medical Ltd., an Israeli developer of an innovative implantable device for the treatment of benign prostatic hyperplasia.